Dose-escalation using intensity-modulated radiotherapy for prostate cancer - Evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 213-219

  Pinkawa, Michael ^a   Attieh, Charbel ^a   Piroth, Marc D ^a   Holy, Richard ^a   Nussen, Sandra ^a   Klotz, Jens ^a   Hawickhorst, Robert ^a   Schäfer, Wolfgang ^a   Eble, Michael J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Choline PET; Dose escalation; Intensity modulated radiotherapy; Prostate neoplasm; Simultaneous integrated boost

Indexed keywords

CHOLINE F 18; CONTRAST MEDIUM; FUROSEMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; HISTOGRAM; HUMAN; IMAGE RECONSTRUCTION; INTENSITY MODULATED RADIATION THERAPY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECTUM; RISK FACTOR; TREATMENT PLANNING; WHOLE BODY CT;

AGED; CHOLINE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350495178     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.07.014     Document Type: Article

References (38)

1. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
2. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
3. Zietman A.L., DeSilvio M., Slater J.D., et al. Comparison of conventional-dose vs. high-dose radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA 294 (2005) 1233-1239
4. Pinkawa M., Pursch-Lee M., Asadpour B., et al. Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intra-fraction motion. Strahlenther Onkol 184 (2008) 679-685
5. McNair H.A., Hansen V.N., Parker C.C., et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71 (2008) 41-50
6. Lee C.T., Dong L., Ahamad A.W., et al. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 28 (2005) 618-625
7. De Meerleer G.O., Vakaet L., Gersem W., et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 47 (2000) 639-648
8. Vitolo V., Millender L., Quivey J.M., et al. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol 90 (2009) 213-220
9. Wang J., Bai S., Chen N., et al. The clinical feasibility of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol 90 (2009) 221-227
10. Cellini N., Morganti A.G., Mattiucci G.C., et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53 (2002) 595-599
11. Chen M.E., Johnston D.A., Tang K., et al. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
12. Farsad M., Schiavina R., Castellucci P., et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46 (2005) 1642-1649
13. 18F-fluorocholine PET. J Nucl Med 47 (2006) 262-269
14. 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging 7 (2008) 12-20
15. Reske S.N., Blumstein N.M., Neumaier B., et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 47 (2006) 1249-1254
16. Yamaguchi T., Lee J., Uemura H., et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32 (2005) 742-748
17. 1H MR spectroscopic imaging - correlation with pathologic findings. Radiology 246 (2008) 480-488
18. Villeirs G.M., Verstraete K.L., De Neve W.J., et al. Magnetic resonance imaging anatomy of the prostate and periprostatic area: a guide for radiotherapists. Radiother Oncol 76 (2005) 99-106
19. Kupelian P.A., Thakkar V.V., Khuntia D., et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 63 (2005) 1463-1468
20. Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1013-1015
21. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. Report 50, Bethesda, MD: ICRU; 1993.
22. Yaparpalvi R., Hong L., Mah D., et al. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription. Radiother Oncol 89 (2009) 347-352
23. Lawton C.A.F., Michalski J., El-Naqa I., et al. RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 74 (2009) 383-387
24. Wu Q., Mohan R., Niemierko A., et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52 (2002) 224-235
25. Dunscombe P.B., Iftody S., Ploquin N., et al. The equivalent uniform dose as a severity metric for radiation treatment incidents. Radiother Oncol 84 (2007) 64-66
26. Emami B., Lyman J.T., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
27. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
28. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal data using different NTCP models: results from an Italian multi-centri study (AIROPROSO101). Radiother Oncol 73 (2004) 21-32
29. McBride W.H., and Withers H.R. Biological basis of radiation therapy. In: Halperin E.C., Perez C.A., and Brady L.W. (Eds). Principles and practice in radiation oncology. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia 76-108
30. De Meerleer G., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 75 (2005) 325-333
31. van Lin E.N., Futterer J.J., Heijmink S.W., et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
32. Thie J.A. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 45 (2004) 1431-1434
33. Sutinen E., Nurmi M., Roivainen A., et al. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 31 (2004) 317-324
34. Fonteyne V., Villeirs G., Speleers B., et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 72 (2008) 799-807
35. Bolla M., Van P.H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
36. Thompson Jr. I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329-2335
37. King C.R., Kapp D.S., King C.R., et al. Radiotherapy after prostatectomy: is the evidence for dose escalation out there?. Int J Radiat Oncol Biol Phys 71 (2008) 346-350
38. Anscher M.S., Clough R., and Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 48 (2000) 369-375